Hermetica Superfood Encyclopedia
The Short Answer
Gloriosa superba contains the alkaloid colchicine, which exerts its primary pharmacological effects by binding β-tubulin and preventing microtubule polymerization, thereby disrupting mitosis, suppressing neutrophil motility, and inhibiting lipoxygenase-mediated inflammation by up to 90% in vitro. In preclinical models, methanolic seed extracts demonstrated an IC₅₀ of 19.52 µg/mL against MDA-MB-231 breast cancer cells, and tuber extracts produced a 20 mm inhibition zone against MRSA, though no human clinical trials have validated these effects.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordGloriosa superba benefits
Flame Lily — botanical close-up
Health Benefits
**Antimicrobial Activity**: Tuber and seed extracts of G
superba exhibit broad-spectrum antibacterial activity, with reported 20 mm inhibition zones against methicillin-resistant Staphylococcus aureus (MRSA), attributed to membrane-disrupting phytochemicals including colchicine, gloriosine, and saponins.
**Anti-inflammatory Potential**
Colchicine and gloriosine inhibit lipoxygenase activity by up to 90% in vitro, suppressing leukotriene synthesis and neutrophil degranulation, paralleling the mechanism of pharmaceutical-grade colchicine used clinically for acute gout and pericarditis.
**Anticancer Preclinical Activity**
Methanolic seed extracts showed IC₅₀ values of 19.52 µg/mL against MDA-MB-231 triple-negative breast cancer cells via MTT assay, achieving 60–80% cytotoxicity at 50 µg/mL, driven by colchicine's disruption of the mitotic spindle apparatus.
**Cholinesterase Inhibition**: Ethyl acetate fractions of G
superba inhibit acetylcholinesterase (AChE) by 83.50% and butyrylcholinesterase (BChE) by 29.10% in vitro, suggesting potential neuroprotective relevance through preservation of cholinergic neurotransmission, though no human data exist.
**Antifertility and Anthelmintic Traditional Uses**
Decoctions of rhizomes have been employed as abortifacients in Ayurvedic and African ethnomedicine, a property attributable to colchicine's anti-mitotic disruption of rapidly dividing trophoblastic cells, alongside documented anthelmintic applications against intestinal parasites.
**Cytogenetic and Polyploidy Induction**: Colchicine isolated from G
superba is commercially exploited in plant breeding to arrest cells in metaphase, enabling chromosome doubling and production of polyploid crop varieties with enhanced agronomic traits, representing one of its most validated applied uses.
**Analgesic and Antirheumatic Properties**
Traditional Ethiopian and Ayurvedic preparations applied rhizome pastes topically and internally for rheumatism and joint pain, an effect mechanistically consistent with colchicine's documented suppression of IL-1β secretion and NLRP3 inflammasome activation at microgram-level doses.
Origin & History
Natural habitat
Gloriosa superba is indigenous to tropical and southern Africa, extending across the Indian subcontinent through Sri Lanka, India, and Southeast Asia, thriving in sandy soils, forest margins, and grasslands at low to moderate altitudes. The plant climbs via leaf-tip tendrils and produces distinctive red-and-yellow flame-shaped flowers, growing from underground corms (rhizomes) that serve as the primary repository of bioactive alkaloids. It is the national flower of Zimbabwe and is cultivated commercially in India, particularly in Tamil Nadu, West Bengal, and Sikkim, where elite chemotypes such as GS-1, GS-2, and GS-3 are selected for elevated colchicine content.
“Gloriosa superba has been documented in Ayurvedic texts (Charaka Samhita and Sushruta Samhita) under the Sanskrit name Langli or Kalihari, where it was prescribed for rheumatism, gout, hemorrhoids, intestinal parasites, and as an abortifacient, typically prepared as a carefully dosed rhizome decoction under the supervision of a vaidya. In Ethiopian and broader East African traditional medicine, the plant's rhizomes and leaves were employed as antimicrobial agents applied to wounds and skin infections, and the plant held significance in ritual and poison-craft contexts due to its visually striking flowers and potent toxicity. Historically, G. superba was used in certain regions as a source of arrow poison and has been implicated in cases of deliberate poisoning across South Asia, leading to its classification as a scheduled plant in India under the Wildlife Protection Act. Zimbabwe designated Gloriosa superba its national flower in recognition of its ecological prominence and cultural identity across the region, and the plant remains a symbol of beauty and danger throughout its native range.”Traditional Medicine
Scientific Research
The existing evidence base for Gloriosa superba is entirely preclinical, comprising in vitro bioassays and a limited number of animal pharmacology studies, with zero registered or completed human clinical trials identified in the available literature. Key in vitro findings include an IC₅₀ of 19.52 µg/mL for methanolic seed extracts against MDA-MB-231 breast cancer cells (compared to doxorubicin as reference), 90% lipoxygenase inhibition from plant alkaloid fractions, and 20 mm MRSA inhibition zones from tuber extracts, but none of these results have been replicated in controlled animal efficacy models with standardized dosing. Chemotypic variation across 32 Indian populations (colchicine range 2.12–7.58 mg/g in rhizomes) documented via HPLC introduces substantial batch-to-batch inconsistency that would complicate any future clinical standardization. The evidence quality is rated very low by GRADE criteria; all reported bioactivities must be interpreted as hypothesis-generating rather than clinically actionable.
Preparation & Dosage
Traditional preparation
**Traditional Rhizome Decoction**
Dried rhizomes historically boiled in water at low concentrations for anti-rheumatic application in Ethiopian and Ayurvedic systems; exact doses unquantified and historically associated with toxicity events.
**Topical Paste**
Ground rhizome mixed with carrier oils or water applied externally for joint pain and snakebite in African traditional medicine; systemic absorption through intact skin is limited but not absent.
**Methanolic/Ethyl Acetate Laboratory Extracts**
30–60 mg/mL (antimicrobial) concentrations in vitro; these are not formulations intended or safe for human oral use
Used in research at 19.52–60 µg/mL (anticancer) and .
**Pharmaceutical Colchicine Reference Dose**
2 mg/day orally for acute gout; this cannot be used as a dosing guide for raw plant preparations due to variable alkaloid content
Isolated pharmaceutical colchicine (not plant extract) is dosed at 0.5–1..
**No Established Supplement Form**
G. superba is not available as a standardized dietary supplement; no capsule, tablet, or tincture form has been approved or validated for human consumption.
**Standardization Note**
58 mg colchicine/g dry rhizome; even small quantities of unprocessed rhizome or seed powder can exceed toxic thresholds
Elite Indian chemotypes (GS-1, GS-3) yield up to 7..
Nutritional Profile
Gloriosa superba is not a nutritional food source and provides no meaningful macronutrient contribution; it is consumed exclusively in medicinal contexts at sub-gram quantities due to toxicity. The primary phytochemical profile includes colchicine at 1.5–9 mg/g dry weight (highest in seeds at 6–9 mg/g, rhizomes at 1.5–3 mg/g), gloriosine (a tropolone alkaloid structurally related to colchicine), and colchicoside (a glycosylated colchicine derivative). Secondary metabolites identified via GC-MS and FTIR include β-sitosterol, lupeol, salicylic acid, benzoic acid, α-lumicolchicine, flavonoids (quercetin derivatives), and saponins, with seeds yielding 17 identifiable compounds and tubers yielding 9. Bioavailability of colchicine from plant extracts in humans is uncharacterized; pharmaceutical colchicine has oral bioavailability of approximately 45% with a Tmax of 0.5–3 hours and renal excretion, but these parameters do not necessarily apply to crude extract formulations.
How It Works
Mechanism of Action
Colchicine, the primary alkaloid in G. superba rhizomes and seeds (1.5–9 mg/g dry weight), binds with high affinity to the colchicine-binding site on β-tubulin at the intradimer interface, preventing GTP-dependent polymerization of tubulin dimers into functional microtubules and inducing mitotic arrest at metaphase, which drives apoptosis in rapidly proliferating cancer and immune cells. In inflammatory cascades, colchicine attenuates neutrophil chemotaxis by depolymerizing cytoskeletal microtubules required for directed cell migration, and suppresses NLRP3 inflammasome assembly, reducing caspase-1 activation and downstream IL-1β and IL-18 secretion. Gloriosine, a structurally related tropolone alkaloid, contributes to AChE inhibition (83.50% in ethyl acetate fractions), likely through competitive or mixed inhibition at the active-site gorge of the enzyme, potentially elevating synaptic acetylcholine levels. Saponins and β-sitosterol in the plant further contribute antimicrobial activity through intercalation into microbial phospholipid bilayers, increasing membrane permeability and disrupting proton gradients essential for bacterial ATP synthesis.
Clinical Evidence
No human clinical trials evaluating G. superba extracts as a therapeutic agent have been conducted or reported in indexed medical literature. The pharmacological rationale for its traditional uses in antimicrobial, anti-inflammatory, and anticancer contexts is supported by mechanism-level in vitro data but has not been translated into Phase I safety trials, dose-finding studies, or efficacy trials with defined endpoints. Pharmaceutical-grade colchicine derived from the related species Colchicum autumnale (and partly from G. superba) has strong clinical validation for acute gout and familial Mediterranean fever, but this evidence cannot be extrapolated to whole-plant G. superba extracts due to unpredictable alkaloid concentrations and coexisting toxic constituents. Confidence in any clinical benefit of G. superba extracts remains negligible pending human studies.
Safety & Interactions
Gloriosa superba is among the most toxic plants documented in ethnopharmacological literature; ingestion of as little as 6 mg of colchicine (equivalent to roughly 1–2 g of seed material) can be lethal in adults, causing a sequential toxidrome of severe gastrointestinal distress (nausea, vomiting, profuse diarrhea), followed by multi-organ failure including bone marrow suppression (agranulocytosis, thrombocytopenia), acute renal failure, hepatotoxicity, neuromuscular paralysis, and cardiovascular collapse within 24–72 hours. Colchicine is a substrate and inhibitor of CYP3A4 and P-glycoprotein; concurrent use of CYP3A4 inhibitors (clarithromycin, azithromycin, ketoconazole, cyclosporine, statins) dramatically increases plasma colchicine levels and toxicity risk, and this interaction applies even at pharmaceutical doses. Absolute contraindications for any G. superba preparation include pregnancy (documented antifertility, abortifacient, and teratogenic effects), lactation, renal impairment (creatinine clearance <30 mL/min), hepatic impairment, hematologic disorders, and use in children. No safe supplemental dose range exists for crude G. superba preparations; self-administration is strongly contraindicated and potentially fatal, and the plant should only be handled under institutional research or licensed pharmaceutical contexts.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Gloriosa superbaGlory LilyClimbing LilyKalihariLangliMalabar Glory LilyFire LilySuperb Lily
Frequently Asked Questions
What is Gloriosa superba used for medicinally?
Gloriosa superba is used in Ayurvedic and African traditional medicine for rheumatism, gout, skin infections, intestinal parasites, and as an abortifacient, primarily through rhizome decoctions or pastes. Its bioactive alkaloid colchicine is the basis for these uses, inhibiting microtubule polymerization and suppressing inflammation via lipoxygenase inhibition (up to 90% in vitro), though no human clinical trials have confirmed efficacy or safety for any of these applications.
Is Flame Lily (Gloriosa superba) dangerous or toxic?
Yes, Gloriosa superba is extremely toxic; all parts of the plant, especially seeds and rhizomes, contain colchicine at concentrations of 6–9 mg/g in seeds and 1.5–3 mg/g in rhizomes, and ingestion of even small amounts can cause fatal multi-organ failure through bone marrow suppression, renal failure, and cardiovascular collapse. The plant has caused numerous documented poisoning deaths across South Asia and Africa, and it is absolutely contraindicated for self-use, during pregnancy, or in individuals with kidney or liver disease.
What is the main active compound in Gloriosa superba?
The primary active compound is colchicine, a tropolone alkaloid present at 1.5–9 mg/g dry weight depending on plant part and chemotype, with seeds containing the highest concentrations (6–9 mg/g). Additional alkaloids include gloriosine and colchicoside, alongside β-sitosterol, flavonoids, saponins, salicylic acid, and benzoic acid, identified through GC-MS and FTIR analysis of tubers and seeds.
Can Gloriosa superba be taken as a supplement?
No established dietary supplement form of Gloriosa superba exists, and its use as a self-administered supplement is strongly contraindicated due to the extreme toxicity of colchicine, which has a very narrow margin between therapeutic and lethal doses. Pharmaceutical colchicine derived from related plants is used at precisely controlled doses of 0.5–1.2 mg/day for gout under medical supervision, but crude G. superba extracts with unpredictable alkaloid content cannot be safely dosed outside a clinical or research setting.
Does Flame Lily have antimicrobial properties against MRSA?
In vitro laboratory studies have shown that tuber extracts of Gloriosa superba produce a 20 mm inhibition zone against methicillin-resistant Staphylococcus aureus (MRSA), an effect attributed to membrane-disrupting phytochemicals including colchicine, saponins, and β-sitosterol. However, these results are from petri-dish experiments and have not been validated in animal models or human trials, so they should not be interpreted as evidence that G. superba can treat MRSA infections in people.
Is Flame Lily safe during pregnancy and breastfeeding?
Flame Lily (Gloriosa superba) should be avoided during pregnancy and breastfeeding due to the presence of colchicine and gloriosine, which are known to have teratogenic and uterotoxic properties. These alkaloids can cross the placenta and may cause fetal harm or be transmitted through breast milk. Pregnant and nursing women should not use this ingredient without explicit medical supervision.
Does Flame Lily interact with common medications?
Gloriosa superba contains colchicine, which is also used as a pharmaceutical for gout and pericarditis, raising the risk of additive toxicity if combined with colchicine medications or other drugs metabolized by CYP3A4. The alkaloids in Flame Lily may also potentiate anti-inflammatory drugs and affect immune-modulating therapies. Anyone taking prescription medications should consult a healthcare provider before using this supplement to avoid potentially dangerous interactions.
What does scientific research show about Flame Lily's anti-inflammatory effectiveness in humans?
While in vitro studies demonstrate that colchicine and gloriosine from Gloriosa superba inhibit lipoxygenase activity, clinical human trials specifically evaluating the anti-inflammatory effects of this herb remain limited. Most evidence is derived from laboratory and animal studies rather than controlled human trials, meaning efficacy claims cannot yet be considered definitively proven in clinical populations. Further rigorous human research is needed to establish safe, effective dosing and confirm therapeutic benefits for inflammation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w flame-lily-gloriosa-superba curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
